328 related articles for article (PubMed ID: 30398534)
21. Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
Tsaousis GN; Papadopoulou E; Apessos A; Agiannitopoulos K; Pepe G; Kampouri S; Diamantopoulos N; Floros T; Iosifidou R; Katopodi O; Koumarianou A; Markopoulos C; Papazisis K; Venizelos V; Xanthakis I; Xepapadakis G; Banu E; Eniu DT; Negru S; Stanculeanu DL; Ungureanu A; Ozmen V; Tansan S; Tekinel M; Yalcin S; Nasioulas G
BMC Cancer; 2019 Jun; 19(1):535. PubMed ID: 31159747
[TBL] [Abstract][Full Text] [Related]
22. Assessment of Diagnostic Outcomes of RNA Genetic Testing for Hereditary Cancer.
Karam R; Conner B; LaDuca H; McGoldrick K; Krempely K; Richardson ME; Zimmermann H; Gutierrez S; Reineke P; Hoang L; Allen K; Yussuf A; Farber-Katz S; Rana HQ; Culver S; Lee J; Nashed S; Toppmeyer D; Collins D; Haynes G; Pesaran T; Dolinsky JS; Tippin Davis B; Elliott A; Chao E
JAMA Netw Open; 2019 Oct; 2(10):e1913900. PubMed ID: 31642931
[TBL] [Abstract][Full Text] [Related]
23. Retrospective genotype-phenotype analysis in a 305 patient cohort referred for testing of a targeted epilepsy panel.
Hesse AN; Bevilacqua J; Shankar K; Reddi HV
Epilepsy Res; 2018 Aug; 144():53-61. PubMed ID: 29778030
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic outcomes for genetic testing of 70 genes in 8565 patients with epilepsy and neurodevelopmental disorders.
Lindy AS; Stosser MB; Butler E; Downtain-Pickersgill C; Shanmugham A; Retterer K; Brandt T; Richard G; McKnight DA
Epilepsia; 2018 May; 59(5):1062-1071. PubMed ID: 29655203
[TBL] [Abstract][Full Text] [Related]
25. Epilepsy panels in clinical practice: Yield, variants of uncertain significance, and treatment implications.
Brock DC; Abbott M; Reed L; Kammeyer R; Gibbons M; Angione K; Bernard TJ; Gaskell A; Demarest S
Epilepsy Res; 2023 Jul; 193():107167. PubMed ID: 37230012
[TBL] [Abstract][Full Text] [Related]
26. Genomic testing in pediatric epilepsy.
Thodeson DM; Park JY
Cold Spring Harb Mol Case Stud; 2019 Aug; 5(4):. PubMed ID: 31371349
[TBL] [Abstract][Full Text] [Related]
27. Understanding and interpretation of a variant of uncertain significance (VUS) genetic test result by pediatric providers who do not specialize in genetics.
Menke C; Nagaraj CB; Dawson B; He H; Tawde S; Wakefield EG
J Genet Couns; 2021 Dec; 30(6):1559-1569. PubMed ID: 33969574
[TBL] [Abstract][Full Text] [Related]
28. Early-Life Epilepsies and the Emerging Role of Genetic Testing.
Berg AT; Coryell J; Saneto RP; Grinspan ZM; Alexander JJ; Kekis M; Sullivan JE; Wirrell EC; Shellhaas RA; Mytinger JR; Gaillard WD; Kossoff EH; Valencia I; Knupp KG; Wusthoff C; Keator C; Dobyns WB; Ryan N; Loddenkemper T; Chu CJ; Novotny EJ; Koh S
JAMA Pediatr; 2017 Sep; 171(9):863-871. PubMed ID: 28759667
[TBL] [Abstract][Full Text] [Related]
29. Observed frequency and challenges of variant reclassification in a hereditary cancer clinic.
Macklin S; Durand N; Atwal P; Hines S
Genet Med; 2018 Mar; 20(3):346-350. PubMed ID: 29215655
[TBL] [Abstract][Full Text] [Related]
30. Assessing management practices for variants of uncertain significance among genetic counselors in pediatrics.
Cheung C; Berger SM; Ross M; Kramer T; Li Y; Andrews C; Dergham KR; Spitz E; Florido ME; Ahimaz P
J Genet Couns; 2024 Jan; ():. PubMed ID: 38217320
[TBL] [Abstract][Full Text] [Related]
31. Rapid Whole-Genomic Sequencing and a Targeted Neonatal Gene Panel in Infants With a Suspected Genetic Disorder.
Maron JL; Kingsmore S; Gelb BD; Vockley J; Wigby K; Bragg J; Stroustrup A; Poindexter B; Suhrie K; Kim JH; Diacovo T; Powell CM; Trembath A; Guidugli L; Ellsworth KA; Reed D; Kurfiss A; Breeze JL; Trinquart L; Davis JM
JAMA; 2023 Jul; 330(2):161-169. PubMed ID: 37432431
[TBL] [Abstract][Full Text] [Related]
32. Reinterpretation, reclassification, and its downstream effects: challenges for clinical laboratory geneticists.
El Mecky J; Johansson L; Plantinga M; Fenwick A; Lucassen A; Dijkhuizen T; van der Hout A; Lyle K; van Langen I
BMC Med Genomics; 2019 Nov; 12(1):170. PubMed ID: 31779608
[TBL] [Abstract][Full Text] [Related]
33. The Clinical Variant Analysis Tool: Analyzing the evidence supporting reported genomic variation in clinical practice.
Chin HL; Gazzaz N; Huynh S; Handra I; Warnock L; Moller-Hansen A; Boerkoel P; Jacobsen JOB; du Souich C; Zhang N; Shefchek K; Prentice LM; Washington N; Haendel M; Armstrong L; Clarke L; Li WL; Smedley D; Robinson PN; Boerkoel CF
Genet Med; 2022 Jul; 24(7):1512-1522. PubMed ID: 35442193
[TBL] [Abstract][Full Text] [Related]
34. Reanalysis of eMERGE phase III sequence variants in 10,500 participants and infrastructure to support the automated return of knowledge updates.
Zouk H; Yu W; Oza A; Hawley M; Vijay Kumar PK; Koch C; Mahanta LM; Harley JB; Jarvik GP; Karlson EW; Leppig KA; Myers MF; Prows CA; Williams MS; Weiss ST; Lebo MS; Rehm HL
Genet Med; 2022 Feb; 24(2):454-462. PubMed ID: 34906510
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of 92 patient-driven family studies for reclassification of variants of uncertain significance.
Tsai GJ; Rañola JMO; Smith C; Garrett LT; Bergquist T; Casadei S; Bowen DJ; Shirts BH
Genet Med; 2019 Jun; 21(6):1435-1442. PubMed ID: 30374176
[TBL] [Abstract][Full Text] [Related]
36. Assessing the clinical utility of protein structural analysis in genomic variant classification: experiences from a diagnostic laboratory.
Caswell RC; Gunning AC; Owens MM; Ellard S; Wright CF
Genome Med; 2022 Jul; 14(1):77. PubMed ID: 35869530
[TBL] [Abstract][Full Text] [Related]
37. Variant classification changes over time in the clinical molecular diagnostic laboratory setting.
Hahn E; Mighton C; Fisher Y; Wong A; Di Gioacchino V; Watkins N; Mayers J; Bombard Y; Charames GS; Lerner-Ellis J
J Med Genet; 2024 Jun; ():. PubMed ID: 38806232
[TBL] [Abstract][Full Text] [Related]
38. Genetic variant burden and adverse outcomes in pediatric cardiomyopathy.
Burstein DS; Gaynor JW; Griffis H; Ritter A; Connor MJO; Rossano JW; Lin KY; Ahrens-Nicklas RC
Pediatr Res; 2021 May; 89(6):1470-1476. PubMed ID: 32746448
[TBL] [Abstract][Full Text] [Related]
39. Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
Kurian AW; Ward KC; Hamilton AS; Deapen DM; Abrahamse P; Bondarenko I; Li Y; Hawley ST; Morrow M; Jagsi R; Katz SJ
JAMA Oncol; 2018 Aug; 4(8):1066-1072. PubMed ID: 29801090
[TBL] [Abstract][Full Text] [Related]
40. The role of a multidisciplinary team in managing variants of uncertain clinical significance in prenatal genetic diagnosis.
Diderich KEM; Klapwijk JE; van der Schoot V; van den Born M; Wilke M; Joosten M; Stuurman KE; Hoefsloot LH; Van Opstal D; Brüggenwirth HT; Srebniak MI
Eur J Med Genet; 2023 Oct; 66(10):104844. PubMed ID: 37709011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
